Transcend Capital Advisors, LLC Astrazeneca PLC Transaction History

Transcend Capital Advisors, LLC

$1.42 Billion
Q3 2025

A detailed history of Transcend Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 16,573 shares of AZN stock, worth $1.48 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

16,573

Previous 18,275 9.31%

Holding current value

$1.48 Million

Previous $1.28 Million 0.47%

% of portfolio

0.09%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$68.72 - $82.11 $116,961 - $139,751	-1,702 Reduced 9.31%	16,573 $1.27 Million
Q2 2025 Aug 01, 2025	SELL	$64.87 - $75.0 $2.25 Million - $2.6 Million	-34,616 Reduced 65.45%	18,275 $1.28 Million
Q1 2025 Apr 24, 2025	SELL	$65.37 - $77.96 $1.29 Million - $1.54 Million	-19,729 Reduced 27.17%	52,891 $3.89 Million
Q4 2024 Feb 03, 2025	SELL	$63.2 - $79.58 $341,090 - $429,493	-5,397 Reduced 6.92%	72,620 $4.76 Million
Q3 2024 Oct 15, 2024	BUY	$76.67 - $87.62 $8,050 - $9,200	105 Added 0.13%	78,017 $6.08 Million

Q2 2024 Jul 02, 2024	BUY	$66.81 - $80.83 $3.77 Million - $4.56 Million	56,397 Added 262.13%	77,912 $6.08 Million
Q1 2024 May 03, 2024	BUY	$61.03 - $69.57 $1.31 Million - $1.5 Million	21,515 New	21,515 $1.46 Million
Q2 2023 Jul 13, 2023	SELL	$69.91 - $75.81 $17,757 - $19,255	-254 Reduced 7.89%	2,967 $212,000
Q1 2023 Apr 12, 2023	SELL	$63.15 - $71.6 $77,295 - $87,638	-1,224 Reduced 27.54%	3,221 $223,000
Q4 2022 Jan 20, 2023	SELL	$54.21 - $70.44 $22,551 - $29,303	-416 Reduced 8.56%	4,445 $0
Q3 2022 Oct 17, 2022	SELL	$53.02 - $135.75 $41,726 - $106,835	-787 Reduced 13.93%	4,861 $267,000
Q2 2022 Jul 12, 2022	BUY	$59.26 - $71.14 $12,029 - $14,441	203 Added 3.73%	5,648 $373,000
Q1 2022 Apr 20, 2022	BUY	$55.72 - $67.12 $7,689 - $9,262	138 Added 2.6%	5,445 $361,000
Q4 2021 Jan 20, 2022	BUY	$54.02 - $63.83 $41,919 - $49,532	776 Added 17.13%	5,307 $309,000
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $333 - $364	-6 Reduced 0.13%	4,531 $282,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $115,626 - $143,709	-2,388 Reduced 34.48%	4,537 $271,000
Q1 2021 May 12, 2021	BUY	$47.16 - $54.44 $79,747 - $92,058	1,691 Added 32.31%	6,925 $346,000
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $253,953 - $303,676	5,234 New	5,234 $262,000

Others Institutions Holding AZN

# of Institutions

1,517

Shares Held

502M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Astrazeneca PLC Transaction History